Skip to Main Content

Paper Details

Using time-weighted average change from baseline of SARS-CoV-2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID-19.
J Med Virol
1
2022
COVID-, HCQ, SARS, SARS-CoV-2, hydroxychloroquine
Author NameAffiliation
Raphael J Landovitzuniversity of california los angeles Center for Clinical AIDS Research & Education (CARE), University of California
Raphael J Landovitzuniversity of california los angeles Center for Clinical AIDS Research & Education (CARE), University of California
Keith R JeromeFred Hutchinson Cancer Research Center
Keith R JeromeUniversity of Washington
Alexander L GreningerFred Hutchinson Cancer Research Center
Alexander L GreningerUniversity of Washington
Anna WaldUniversity of Washington
Anna WaldFred Hutchinson Cancer Research Center
Anna WaldUniversity of Washington
Anna WaldUniversity of Washington
  • 1 - 10

Datasets

Release 1.2